QualityStocksNewsBreaks – Endonovo Therapeutics Inc. (ENDVD) Provides SofPulse(R) Evaluation Units to All NFL Teams
Endonovo Therapeutics (OTCQB: ENDVD), a commercial-stage developer of noninvasive Electroceutical(R) therapeutic devices, today announced the delivery of SofPulse(R) evaluation units to all thirty-two National Football League (“NFL”) teams. “With injuries affecting the NFL more than any other professional sports league, we are pleased to support the health of NFL players by providing SofPulse(R) evaluation units to all NFL teams,” Endonovo Therapeutics CEO Alan Collier said in the news release. “The SofPulse(R) device is clinically proven to reduce post-operative pain, swelling and need for opioids. Endonovo is committed to helping NFL players get back on the field faster when recovering from…